rs121918657
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_003172.4(SURF1):c.751C>T(p.Gln251*) variant causes a stop gained, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000109 in 1,461,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_003172.4 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SURF1 | NM_003172.4 | c.751C>T | p.Gln251* | stop_gained, splice_region_variant | 7/9 | ENST00000371974.8 | NP_003163.1 | |
SURF1 | NM_001280787.1 | c.424C>T | p.Gln142* | stop_gained, splice_region_variant | 6/8 | NP_001267716.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SURF1 | ENST00000371974.8 | c.751C>T | p.Gln251* | stop_gained, splice_region_variant | 7/9 | 1 | NM_003172.4 | ENSP00000361042.3 | ||
SURF1 | ENST00000615505.4 | c.424C>T | p.Gln142* | stop_gained, splice_region_variant | 6/8 | 1 | ENSP00000482067.1 | |||
SURF1 | ENST00000437995.1 | n.661C>T | splice_region_variant, non_coding_transcript_exon_variant | 6/8 | 5 | |||||
SURF1 | ENST00000495952.5 | n.741C>T | splice_region_variant, non_coding_transcript_exon_variant | 3/5 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251466Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135918
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461874Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727236
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Leigh syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 04, 2023 | This sequence change creates a premature translational stop signal (p.Gln251*) in the SURF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SURF1 are known to be pathogenic (PMID: 10443880, 22488715, 24027061). This variant is present in population databases (rs121918657, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with clinical features of SURF1-related conditions (PMID: 9837813, 28639102, 32445240). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 12762). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 10, 2016 | Variant summary: The c.751C>T variant results in a premature termination codon, predicted to cause a truncated or absent SURF1 protein, which is a commonly known mechanism for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g.c.758_759delCA/p.Thr253fsX38). One in-silico tool predicts damaging outcome for this variant. This variant is found in 1/121348 control chromosomes at a frequency of 0.0000082, which does not significantly exceed maximal expected frequency of a pathogenic allele (0.0017678). This variant has been reported in 5 LS patients in homozygous or compound heterozygous state. Furthermore, independent studies showed that cells derived from patients have been shown to have reduced COX activity. Additionally, multiple reputable databases classified this variant as pathogenic. Taken together, this variant was classified as pathogenic. - |
Mitochondrial complex IV deficiency, nuclear type 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 1998 | - - |
Mitochondrial disease Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Feb 16, 2023 | The SURF1 c.751C>T (p.Gln251Ter) nonsense variant results in the premature termination of the protein at amino acid position 251. Loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay is expected. This variant has been reported several times in the literature including in a homozygous or compound heterozygous state (PMID: 9837813; PMID: 23829769; PMID: 34302356). This variant is reported in the Genome Aggregation Database in three alleles at a frequency of 0.000012 in the Total population (version 2.1.1). This variant was identified in trans with a pathogenic variant. Based on the available evidence, the c.751C>T (p.Gln251Ter) variant is classified as pathogenic for primary mitochondrial disorder. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 28, 2018 | The Q251X variant has been published in association with Leigh syndrome associated with cytochrome c oxidase deficiency (Tiranti et al. 1998). The Q251X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. In summary, we interpret this variant as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at